Our previous research demonstrated that, following brain ischemic injury, picroside II can remove free radicals, has antioxidant properties, decreases MMP-9 expression and inhibits the toll-like receptor 4 and nuclear factor kappa B (TLR4-NFκB) signaling pathways to relieve cerebral edema. The gene discussed is TLR4; the disease is edema.